cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.38+0.01 (+1.42%)
Close on Nov 19, 2026Market cap $4.25MP/E –Yield –
cbdMD free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
cbdMD's free cash flow for the twelve months ending Jun 30, 2026 was -$2.41M. For fiscal 2025 it was -$1.64M. The highest annual figure on record is -$542.81K in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$1.64M | – |
| FY2024 | Sep 30, 2024 | -$542.81K | – |
| FY2023 | Sep 30, 2023 | -$4.60M | – |
| FY2022 | Sep 30, 2022 | -$15.66M | – |
| FY2021 | Sep 30, 2021 | -$14.44M | – |
| FY2020 | Sep 30, 2020 | -$11.98M | – |
| FY2019 | Sep 30, 2019 | -$16.58M | – |
| FY2018 | Sep 30, 2018 | -$5.60M | – |
| FY2017 | Sep 30, 2017 | -$2.34M | – |
| FY2016 | Sep 30, 2016 | -$3.02M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$460.22K | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$728.25K | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$977.27K | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$243.55K | -254.8% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$705.68K | -343.5% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$204.98K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$482.34K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $157.38K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $289.78K | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$699.45K | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$290.52K | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$383.68K | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$342.96K | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$1.63M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$2.24M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$2.15M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.46M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$4.36M | -3122.6% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$4.69M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$3.09M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$2.29M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $144.40K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.19M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$5.51M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$5.43M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$7.16M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$4.85M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$3.39M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$1.17M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$753.82K | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$1.29M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$1.73M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.82M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$905.44K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$133.68K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$763.02K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$535.67K | – |
See a number that looks wrong?